Duncan Moore
At a glance: Duncan Moore is Director at ASP Isotopes (ASPI). Their latest SEC Form 4, filed Apr 17, 2026, reported a sale of $61K. On file: 0 purchase lines ($0) and 1 sale line ($61K).
Disclosed holdings: about $1.2M of ASPI stock: 1,044,928 shares reported on their latest Form 4 (filed Apr 17, 2026), valued at the Nov 20, 2026 close of $1.15. This counts only ASPI shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at ASP Isotopes Inc. (ASPI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Duncan Moore's InsiderPrint
4 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $61K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (3)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- James P. HendersonCFO · VTS · 99% match
- John Patrick Shannon Jr.See Remarks · XERS · 99% match
- James Francis KesslerCEO · RBA · 99% match
- Douglas ValentiCEO · QNST · 97% match
- Sean Davis KellDirector · PRCH · 96% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 17SEC | ASPIASP Isotopes Inc. | Sell Plan | 11,6421,044,928 held (−1%) | $5.21 | $61K | -78.0% |
- Sell
Director Duncan Moore sold $61K of ASPI at $5.21 — pre-scheduled 10b5-1 plan sale.
Follow Duncan Moore
Get one email when Duncan Moore files a new purchase or sale. Free.
At most one email a day about Duncan Moore, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.